ConductScience.org, home

Paper10604231

Phage therapy: past history and future prospects.

Carlton RM. Arch Immunol Ther Exp (Warsz), 1999. Cited by 191 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Phage therapy: past history and future prospects. Papers, record 10604231. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10604231

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Phage therapy: past history and future prospects.
PubMed
Journal
Arch Immunol Ther Exp (Warsz)
PubMed
Year
1999
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
191
iCite
Relative citation ratio, by iCite
5.2
iCite
Revised in PubMed
2024-01-09
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Carlton RMR M

Source PubMed

Topics27

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial InfectionsMajor topic
BacteriophagesMajor topic
Administration, Oral
Animals
Anti-Bacterial Agents
Antibodies, Viral
Bacteremia
Bacteriophage lambda
Chickens
Clinical Trials as Topic
Combined Modality Therapy
Drug Resistance, Microbial
Drug Resistance, Multiple
Escherichia coli Infections
Europe, Eastern
Forecasting
Genetic Engineering
Humans
Lysogeny
Metabolic Clearance Rate
Mice
Pharmacokinetics
Rabbits
Rats
Research Design
Therapeutics
Treatment Outcome

Source PubMed

Cited by109

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 191 citations.

PMIDTitleJournalYearIn PapersSource
41,305,429Potential Vaccine or Antimicrobial Reagents: Simple Systems for Producing Lambda Display Particles (LDP) and Sheathed Lambda DNA Vaccine Particles (LDNAP).Viruses2025https://conductscience.org/library/papers/41305429PubMed
41,159,315From plaques to pocks: carrying over bacteriophage assay techniques to the study of influenza and other animal viruses.Med Hist2026https://conductscience.org/library/papers/41159315PubMed
40,426,525Isolation and Genomic Analysis of Escherichia coli Phage AUBRB02: Implications for Phage Therapy in Lebanon.Antibiotics (Basel)2025https://conductscience.org/library/papers/40426525PubMed
40,045,606Effects of bacteriophage cocktail supplementation in gestation diet on reproductive performance, blood profile, milk composition, and fecal microflora of sows.Anim Biosci2025https://conductscience.org/library/papers/40045606PubMed
39,728,014Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections.Infect Dis Rep2024https://conductscience.org/library/papers/39728014PubMed
39,452,186Beyond Antibiotics: What the Future Holds.Antibiotics (Basel)2024https://conductscience.org/library/papers/39452186PubMed
39,338,470The Potential of Phage Treatment to Inactivate Planktonic and Biofilm-Forming Pseudomonas aeruginosa.Microorganisms2024https://conductscience.org/library/papers/39338470PubMed
39,205,249Characterization and Anti-Biofilm Activity of Lytic Enterococcus Phage vB_Efs8_KEN04 against Clinical Isolates of Multidrug-Resistant Enterococcus faecalis in Kenya.Viruses2024https://conductscience.org/library/papers/39205249PubMed
38,919,495The trade-off of Vibrio parahaemolyticus between bacteriophage resistance and growth competitiveness.Front Microbiol2024https://conductscience.org/library/papers/38919495PubMed
37,928,478Phage therapy: a revolutionary shift in the management of bacterial infections, pioneering new horizons in clinical practice, and reimagining the arsenal against microbial pathogens.Front Med (Lausanne)2023https://conductscience.org/library/papers/37928478PubMed
37,790,805Case report: Successful treatment of recurrent E. coli infection with bacteriophage therapy for patient suffering from chronic bacterial prostatitis.Front Pharmacol2023https://conductscience.org/library/papers/37790805PubMed
37,764,155The Biotechnological Application of Bacteriophages: What to Do and Where to Go in the Middle of the Post-Antibiotic Era.Microorganisms2023https://conductscience.org/library/papers/37764155PubMed
37,579,848The characterization and genome analysis of a novel phage phiA034 targeting multiple species of Aeromonas.Virus Res2023https://conductscience.org/library/papers/37579848PubMed
37,545,854Isolation and characterization of a novel mycobacteriophage Kashi-VT1 infecting Mycobacterium species.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/37545854PubMed
37,500,690Effects of bacteriophage on Salmonella Enteritidis infection in broilers.Sci Rep2023https://conductscience.org/library/papers/37500690PubMed
37,404,162Class-Driven Synergy and Antagonism between a Pseudomonas Phage and Antibiotics.Infect Immun2023https://conductscience.org/library/papers/37404162PubMed
36,978,455Detection and Level Evaluation of Antibodies Specific to Environmental Bacteriophage I11mO19 and Related Coliphages in Non-Immunized Human Sera.Antibiotics (Basel)2023https://conductscience.org/library/papers/36978455PubMed
35,631,831Incorporation of Mycobacteriophage Fulbright into Polycaprolactone Electrospun Nanofiber Wound Dressing.Polymers (Basel)2022https://conductscience.org/library/papers/35631831PubMed
34,938,668Prospects of Inhaled Phage Therapy for Combatting Pulmonary Infections.Front Cell Infect Microbiol2021https://conductscience.org/library/papers/34938668PubMed
34,759,899vB-ApyS-JF1, the First Trueperella pyogenes Phage, Shows Potential as an Alternative Treatment Strategy for Trueperella pyogenes Infections.Front Microbiol2021https://conductscience.org/library/papers/34759899PubMed

See all 109 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10604231

GET https://conductscience.org/api/papers/v1/10604231/cited_by?page=2